Parkinson’s Disease Clinical Trials
Clinical trials are a crucial step in discovering the causes, treatments, and a cure for Parkinson’s. Before drugs can be approved to be used in a patient population they are rigorously reviewed through the mechanism of a clinical trial.
Below is information on research studies that are taking place at various locations across the country. Although APDA has not individually reviewed or specifically endorsed each study posted here, each has been reviewed and approved by the Institutional Review Board at its respective medical center.
For further information on any study posted here, please utilize the specific contact information provided with the description of the actual study in which you are interested. As always, consult your physician to discuss the individual benefits and risks of each study prior to participating.
Webinar: Spotlight On Clinical Trials
Here is an overview of the APDA webinar on Parkinson’s clinical trials, hosted on 9.17.21, including why clinical trials are vital to Parkinson’s research and how to participate.
To increase your awareness and connect you with ongoing research and clinical trials visit:
Active Clinical Trials
PARAISO Parkinson’s Disease Clinical Trial
Roche and Genentech are evaluating the efficacy and safety of an investigational drug, prasinezumab, for early-stage Parkinson’s Disease.
Eligibility Criteria:
- Age: 50 to 85 years old.
- Diagnosis: Diagnosed with Parkinson’s Disease within the last 3 months to 3 years.
- Medication: Must be on a stable dose of levodopa for at least 3 months.
Study Requirements:
- Visits: Regular clinic visits approximately every 4 weeks.
- Treatment: Includes intravenous (IV) infusions of either prasinezumab or a placebo.
- Support: Travel and accommodation assistance may be available to help participants.
Contact Information:
- Phone: 1-888-662-6728 (Mon–Fri, 5 AM–5 PM PT)
- Email: global-roche-genentech-trials@gene.com
- For more details: https://connect-mf.trialx.com/PARAISO-3/
Research Participants Needed: Voice Therapy Study for People with Parkinson’s Disease
Researchers at Lehman College are seeking adults with Parkinson’s disease to participate in a study focused on improving voice quality and vocal loudness. Eligible participants must be age 18 or older, have an established Parkinson’s disease diagnosis, and be available for one or more hour-long sessions.
Participants will receive:
- Two free voice therapy sessions
- Voice and cognitive evaluations
- A voice hygiene consultation
This study is led by Maryam Faham, PhD, SLP, in the Department of Speech-Language-Hearing Sciences at Lehman College. For more information or to participate, please contact maryam.faham@lehman.cuny.edu or scan the QR code on the flyer.
Research Participants Needed: Parkinson’s Disease Remote Rehabilitation Study
Researchers at Virginia Tech are seeking individuals with Parkinson’s disease to participate in a remote research study focused on improving rehabilitation through haptic (touch-based) guidance technology. Participation can be completed from home, and participants will receive $100 upon completion of the study.
To learn more or determine eligibility, please complete the screening survey or contact the research team directly at anannyak@vt.edu.
Survey: https://bit.ly/pdremotescreen
This study has been approved by the Virginia Tech Institutional Review Board (IRB-25-839).
Have You Been Diagnosed with Parkinson’s Disease (PD)? Do You Know or Care for Someone With PD?
The goal of the REGENERATE-PD study is to test whether a new gene therapy (AB-1005) is safe and effective for patients with PD. This therapy aims to introduce working GDNF to your brain, which promotes the survival of braincells.
Thank you for your interest in the investigational REGENERATE-PD study. Your participation in this study may help scientists and physicians better understand PD and how to improve treatment. Your participation may contribute to the medical field and may make a positive impact on the lives of people affected by PD.
For more information, please contact AskFirst@askbio.com or scan the QR code below:
https://mytomorro.ws/pd-askfirst
ClinicalTrials.gov/study/NCT06285643
Please review AskBio’s Privacy Notice at www.askbio.com/privacy
Lend Your Voice To Parkinson’s Research
If you are age 18-100 and you have a Parkinson’s Disease diagnosis, no history of stroke, brain tumor, or other neurological conditions…you may be eligible to participate!
Our Studies involve:
- Symptom questionnairesm,
- Reading and speaking,
- Hearing and cognition screenings
- Wearing a microphone and sensors
- $30/hr and travel assistance
617-358-1395
stepplab@gmail.com
111 Cummington Mall
sites.bu.edu/stepplab/
IRB Protocol #2625
PI: Dr. Cara Stepp
Rehabilitation of Airway Protection in Parkinson’s Disease:
Comparing In-Person and Telehealth Service Delivery Models
Are you interested in improving your swallowing and cough function? If yes, you may be eligible to participate in a research study!
WHO: Adults with Parkinson’s disease who have swallowing and cough difficulties. Ages 50 to 90.
WHAT: You will receive free evaluations and treatment of your cough and swallowing issues.
WHERE: Teachers College, Columbia University
TIME COMMITMENT: At least 5 in-person evaluations and 16 treatment visits over 15 months. Visits will be between 60-90 minutes.
Receive up to $200 for participation.
Click here for more information.
Speech Accessibility Project
Share your voice with the Speech Accessibility Project!
Now recruiting individuals with Parkinson’s to help speech recognition tools
understand diverse voices, including those affected by Parkinson’s and related
neurological diagnoses, for example, MSA, PSP, CBD, post-DBS, and LBD.
All personal information safeguarded at the University of Illinois Urbana-Champaign.
Project funded by Amazon, Apple, Google, Meta, and Microsoft.
Record your speech from the comfort of your home. Mentors from LSVT Global are
ready to help you through the participation process.
Get started today! Participants can earn up to $180. Caregivers can earn up to $90,
as well.
go.illinois.edu/SAPregistration
UC San Diego School of Medicine: Caregiver Study
UC San Diego is working on a national research project that is seeking participants caring for family members with Parkinson’s Disease, Alzheimer’s Disease, Lewy Body dementia, or any other type of dementia. This internet-based study aims to help address the stressors that come with being a caregiver and teach coping skills that may reduce that stress and/or improve emotional well-being. Study participants get access to specialized web-programs, monetary compensation, support calls and more. See flyer for more information. Contact 858-534-9479 for details and to see if you qualify.
Learn more about Clinical Trials
Progress in treating Parkinson’s disease (PD) depends on clinical trials, and the success of clinical trials depends on people like you who volunteer to enroll in a trial. Download our brochure to learn about clinical trials, what they can offer you, and how you can learn more.
